What are Selective Serotonin Reuptake Inhibitors primarily classified as?

Selective Serotonin Reuptake Inhibitors (SSRIs) are primarily classified as antidepressant medications. They function by inhibiting the reuptake of serotonin, a neurotransmitter, in the brain, which increases its availability in the synaptic cleft. This increase in serotonin levels is associated with mood enhancement and relief from depressive symptoms, making SSRIs effective treatments for conditions such as major depressive disorder and anxiety disorders.

The classification of SSRIs as antidepressants is due to their primary use for alleviating symptoms of depression. They have become one of the first-line treatments for depression and are also commonly prescribed for anxiety, panic disorders, and certain obsessive-compulsive disorders due to their efficacy and relatively favorable side effect profile compared to older classes of antidepressants.

In contrast, the other classifications listed, such as antipsychotic, anxiolytic, and stimulant medications, serve different purposes in psychiatric treatment. Each class targets different neurotransmitters and is utilized based on specific clinical criteria and mental health conditions.